Characteristics | Early-stage (n = 77) | Advanced-stage (n = 124) | P-value |
---|---|---|---|
Age (years) | 53 (49, 59.5) | 56 (49, 65) | 0.1441 |
CA125 (U/mL) | 229.4 (98.16, 614.5) | 815.95 (249.73, 2187) | < 0.0011 |
CA199 (U/mL) | 12.95 (5.4, 43.83) | 13.03 (7.52, 26.28) | 0.8581 |
Menopause status | Â | Â | 0.7212 |
Yes | 56 (72.7%) | 93 (75%) | Â |
No | 21 (27.3%) | 31 (25%) | Â |
Histologic subtypes |  |  | < 0.0012 |
HGSC | 45 (58.4%) | 116 (93.5%) | Â |
Non-HGSC | 32 (41.6%) | 8 (6.5%) | Â |
Ki-67 expression | Â | Â | 0.3502 |
≤ 50 | 40 (51.9%) | 56 (45.2%) |  |
> 50 | 37 (48.1%) | 68 (54.8%) |  |
Tumor location |  |  | < 0.0012 |
Bilateral | 26 (33.8%) | 80 (64.5%) | Â |
Unilateral | 51 (66.2%) | 44 (35.5%) | Â |
Peritoneal metastasis |  |  | < 0.0012 |
Yes | 8 (10.4%) | 94 (75.8%) | Â |
No | 69 (89.6%) | 30 (24.2%) | Â |